Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study evaluating oral insulin to reduce liver fat in type 2 diabetes patients with nonalcoholic steatohepatitis has completed with r…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Dapagliflozin Efficacy and Action in NASH [Phase 3]
Phase 3 clinical trial update evaluating dapagliflozin for efficacy and action in nonalcoholic steatohepatitis (NASH) completed.
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Study to Evaluate MET642 in Patients With NASH [Phase 2]
Phase 2 trial update for MET642 in nonalcoholic steatohepatitis (NASH) has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers [Phase 2]
Phase 2a study of HU6 in subjects with elevated liver fat and high BMI related to nonalcoholic steatohepatitis (NASH) has completed with res…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis [Phase 3]
Phase 3 study evaluating efficacy and safety of MGL-3196 (Resmetirom) in patients with NASH and fibrosis is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Norursodeoxycholic Acid vs. Placebo in NASH [Phase 2]
Phase 2 trial update for Norursodeoxycholic Acid versus placebo in nonalcoholic steatohepatitis is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. [Phase 2]
Phase 2 study evaluating the efficacy, safety and tolerability of the combination of Tropifexor and Licogliflozin, as well as each monothera…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 trial update for oral LPCN 1144 in nonalcoholic steatohepatitis (NASH) has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH [Phase 2]
Phase 2 trial assessing CS0159 in nonalcoholic steatohepatitis (NASH) has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) [Phase 2]
Phase 2 clinical trial of efinopegdutide (MK-6024) in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has completed with r…
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transfer for efficacy, safety, and tolerability in patients with nonalcoholic steatohepat…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis [Phase 3]
Phase 3 study evaluating obeticholic acid for compensated cirrhosis due to nonalcoholic steatohepatitis has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients [Phase 4]
Phase 4 trial comparing raltegravir-based antiretroviral therapy to maintaining any other ART in HIV mono-infected patients; completed study…
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial update for PXL065 in nonalcoholic steatohepatitis (NASH) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease [NA]
A clinical trial investigating quantitative ultrasound with Liver InCytes for evaluating non-alcoholic fatty liver disease was terminated; r…
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Vitamin E for NASH Treatment in HIV Infected Individuals [Phase 2]
A Phase 2 trial studying vitamin E for treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in individuals with HIV wa…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Noninvasive Biomarkers of Metabolic Liver Disease 1.1 [NA]
A completed clinical trial from Massachusetts General Hospital investigating noninvasive biomarkers for metabolic liver disease, including n…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis [Phase 3]
Clinical trial comparing rosuvastatin to CoQ10 for nonalcoholic steatohepatitis in Phase 3; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: CM-101 in NASH Patients - The SPLASH Study [Phase 2]
Phase 2 trial update for CM-101 in nonalcoholic steatohepatitis (NASH) from the SPLASH study; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial assessing pharmacodynamics and safety of coadministered DGAT2 inhibitor and ACC inhibitor in participants with presum…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD [Phase 1, Phase 2]
Phase Ib/II trial evaluating GH509 versus placebo for NASH/NAFLD is ongoing; no results yet from the study.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial of leronlimab (PRO 140) in nonalcoholic steatohepatitis (NASH) has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial update for various treatments in NAFLD with aspects of NASH; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluating probiotics for non-alcoholic fatty liver disease and steatohepatitis; results have been pos…